Theralase Technologies Reports First Half Results with Revenue Decline and Net Loss
Theralase Technologies Inc., a publicly traded company on the TSX Venture Exchange, reported first-half results for the period ending June 30th, 2026. The firm recorded revenue of C$2.97 million in the six-month period, representing a year-over-year decline of 4.5%. During this time, Theralase posted a net loss of C$2,093,926. The company's cash balance stood at C$5,260,832 as of June 30th, 2026, compared to just C$182,914 on December 31st, 2025. This significant increase in liquidity suggests a capital raise or financing activity occurred during the first half of the year. The results highlight ongoing financial challenges for Theralase despite improved cash reserves.
Tickers: $TLTFF
Topics: financial_performance net_loss revenue